BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karamyan VT. Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19? Physiol Rep 2021;9:e14796. [PMID: 33687143 DOI: 10.14814/phy2.14796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Méndez-garcía LA, Escobedo G, Minguer-uribe AG, Viurcos-sanabria R, Aguayo-guerrero JA, Carrillo-ruiz JD, Solleiro-villavicencio H. Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations. Front Cell Neurosci 2022;16:977039. [DOI: 10.3389/fncel.2022.977039] [Reference Citation Analysis]
2 Liu X, Cheng T, Liu B, Chi J, Shu T, Wang T. Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development. Front Pharmacol 2022;13:955648. [DOI: 10.3389/fphar.2022.955648] [Reference Citation Analysis]
3 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 da Silva MF, de Araújo-Júnior JX, da Silva-Júnior EF, Heimfarth L, Martins-Filho PR, Quintans JSS, Quintans-Júnior LJ. Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives. Naunyn Schmiedebergs Arch Pharmacol 2022;395:275-83. [PMID: 35089406 DOI: 10.1007/s00210-022-02206-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lumbers ER, Head R, Smith GR, Delforce SJ, Jarrott B, H Martin J, Pringle KG. The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment. Pharmacol Res Perspect 2022;10:e00917. [PMID: 35106954 DOI: 10.1002/prp2.917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
6 Dabholkar N, Gorantla S, Dubey SK, Alexander A, Taliyan R, Singhvi G. Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations. Biomed Pharmacother 2021;142:112023. [PMID: 34399199 DOI: 10.1016/j.biopha.2021.112023] [Cited by in F6Publishing: 6] [Reference Citation Analysis]